Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Jan;2(1):30–34. doi: 10.1128/cdli.2.1.30-34.1995

Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.

M Theisen 1, J Vuust 1, A Gottschau 1, S Jepsen 1, B Høgh 1
PMCID: PMC170096  PMID: 7719909

Abstract

A recombinant Plasmodium falciparum glutamate-rich protein (GLURP) was produced in Escherichia coli as a nearly full-length protein. In order to map immunodominant regions on GLURP, the nonrepetitive amino-terminal region (R0) as well as the central repeat region (R1) and the carboxy-terminal repeat region (R2) were also produced as separate products. All four purified gene products reacted specifically with serum samples from adults living in an area of Liberia where malaria is holoendemic. It appears that the human immune response against GLURP is primarily directed against the R2 region because 94% of the serum samples reacted with this region in an immunoassay. Antibody reactivity against the R0 region was also observed in 75% of the serum samples, while the R1 region showed only weak antibody-binding activity. When the nearly full-length GLURP molecule was adsorbed to Al(OH)3 it was found to be immunogenic in mice. In these experiments, the antibody response was almost exclusively directed against the R2 region. When anti-GLURP sera were obtained from rabbits immunized with the three regions, R0, R1, and R2, respectively, they recognized in immunoprecipitation experiments authentic GLURP from P. falciparum grown in vitro. These results demonstrate that GLURP produced in E. coli can induce a humoral immune response against GLURP derived from blood-stage parasites.

Full Text

The Full Text of this article is available as a PDF (223.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders R. F., Coppel R. L., Brown G. V., Kemp D. J. Antigens with repeated amino acid sequences from the asexual blood stages of Plasmodium falciparum. Prog Allergy. 1988;41:148–172. [PubMed] [Google Scholar]
  2. Borre M. B., Dziegiel M., Høgh B., Petersen E., Rieneck K., Riley E., Meis J. F., Aikawa M., Nakamura K., Harada M. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol Biochem Parasitol. 1991 Nov;49(1):119–131. doi: 10.1016/0166-6851(91)90135-s. [DOI] [PubMed] [Google Scholar]
  3. Boudin C., Chumpitazi B., Dziegiel M., Peyron F., Picot S., Hogh B., Ambroise-Thomas P. Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso. J Clin Microbiol. 1993 Mar;31(3):636–641. doi: 10.1128/jcm.31.3.636-641.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  5. Dziegiel M., Borre M. B., Jepsen S., Hogh B., Petersen E., Vuust J. Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 1991 Mar;44(3):306–313. doi: 10.4269/ajtmh.1991.44.306. [DOI] [PubMed] [Google Scholar]
  6. Dziegiel M., Borre M. B., Petersen E., Högh B., Jepsen S., Vuust J., Axelsen N. Capture ELISA for IgM antibodies against Plasmodium falciparum glutamate rich protein. J Immunol Methods. 1992 Nov 5;155(2):207–213. doi: 10.1016/0022-1759(92)90287-4. [DOI] [PubMed] [Google Scholar]
  7. Dziegiel M., Rowe P., Bennett S., Allen S. J., Olerup O., Gottschau A., Borre M., Riley E. M. Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children. Infect Immun. 1993 Jan;61(1):103–108. doi: 10.1128/iai.61.1.103-108.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hogh B., Petersen E., Dziegiel M., David K., Hanson A., Borre M., Holm A., Vuust J., Jepsen S. Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia. Am J Trop Med Hyg. 1992 Mar;46(3):307–313. doi: 10.4269/ajtmh.1992.46.307. [DOI] [PubMed] [Google Scholar]
  9. Jakobsen P. H., Theander T. G., Jensen J. B., Mølbak K., Jepsen S. Soluble Plasmodium falciparum antigens contain carbohydrate moieties important for immune reactivity. J Clin Microbiol. 1987 Nov;25(11):2075–2079. doi: 10.1128/jcm.25.11.2075-2079.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Messing J. New M13 vectors for cloning. Methods Enzymol. 1983;101:20–78. doi: 10.1016/0076-6879(83)01005-8. [DOI] [PubMed] [Google Scholar]
  12. Nussenzweig V., Nussenzweig R. S. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol. 1989;45:283–334. doi: 10.1016/s0065-2776(08)60695-1. [DOI] [PubMed] [Google Scholar]
  13. Romero P. Malaria vaccines. Curr Opin Immunol. 1992 Aug;4(4):432–441. doi: 10.1016/s0952-7915(06)80035-x. [DOI] [PubMed] [Google Scholar]
  14. Theisen M., Cox G., Høgh B., Jepsen S., Vuust J. Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus. Infect Immun. 1994 Aug;62(8):3270–3275. doi: 10.1128/iai.62.8.3270-3275.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Theisen M., Potter A. A. Cloning, sequencing, expression, and functional studies of a 15,000-molecular-weight Haemophilus somnus antigen similar to Escherichia coli ribosomal protein S9. J Bacteriol. 1992 Jan;174(1):17–23. doi: 10.1128/jb.174.1.17-23.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
  17. Van Dyke M. W., Sirito M., Sawadogo M. Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain. Gene. 1992 Feb 1;111(1):99–104. doi: 10.1016/0378-1119(92)90608-r. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES